Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.4462 per EA under NDC 59762100501. Its NADAC has been published 600 times since Dec 31, 2014.
Strength
.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CABERGOLINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020664On Market Since
9/22/2014
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 600 times since Dec 31, 2014, and over the history we have for it it has declined 85.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4462 per EA |
|---|---|
| All-time high | $12.1817 (Apr 13, 2016) |
| All-time low | $1.0692 (Nov 20, 2024) |
| 52-week high | $1.6003 |
| 52-week low | $1.3567 |
| Median price | $2.5150 |
| Average price | $4.2341 |
| Largest weekly change | +45.5% (Nov 18, 2020) |
| Weeks tracked | 600 |
| Tracking since | Dec 31, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.4462 per EA (NDC 59762100501), effective Jun 24, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 85.0%. It has been tracked across 600 weekly CMS publications since Dec 31, 2014.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Dec 31, 2014, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.0692 (Nov 20, 2024) to a high of $12.1817 (Apr 13, 2016), with a median of $2.5150 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CABERGOLINE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 59762100501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification